Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human FcRn-binding modified antibodies and methods of use

Human FcRn-binding modified antibodies and methods of use

US Patent 11091541 · Granted Aug 17, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the generation of an FCRN expressing cell by targeted integration of 2025
Vitro prediction of in vivo half-life2025
Methods of treating cancer by administering tumor necrosis factor (TNF) family l2025
Method for producing bispecific antibodies comprising a Y436A Fc-region mutation2025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Humanized anti-Tau(PS422) antibodies and methods of use2025
Fc-receptor binding modified asymmetric antibodies and methods of use2025
Fc-receptor binding modified asymmetric antibodies and methods of use2025
Fc-receptor binding modified asymmetric antibodies and methods of use2025